Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Icosapent Ethyl and Prevention of Vascular Regenerative Cell Exhaustion Study

NCT04562467 is registered in ClinicalTrials.gov with Canadian Medical and Surgical Knowledge Translation Research Group as lead sponsor.

NCT NCT04562467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04562467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Icosapent Ethyl and Prevention of Vascular Regenerative Cell Exhaustion Study
Lead sponsor
Canadian Medical and Surgical Knowledge Translation Research Group
Phase
Phase 4
Overall status
Completed
Start date
September 24, 2020
Completion date
May 25, 2023
Enrollment
70 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular risk factor, diabetes mellitus, type 2, triglycerides high